DigiCon

@if (isset(session()->get('doctor')['vCentralCode']))

Back

@else

@endif

A survey among Indian healthcare practitioners to understand In-Practice usage of tamsulosin and dutasteride in management of BPH patients with co-morbid conditions

Survey Questionnaire Form

Doctor's details

Questionnaire

In your clinical practice, what is the average number of BOO (Bladder Outlet Obstruction) patients with enlarged prostate (volume >30cc) you consult per month? *

<10 pts

10-20 pts

>20 pts

In your clinical practice, of these BOO/BPH patients how many patients are on concomitant medications for comorbid conditions (anti-Hypertensive/anti-Diabetic, statins, antiplatelets, etc.)? *

<5%

5-10%

10-15%

15-20%

>20%

In your clinical practice, which is the most common comorbid condition in these BOO/BPH patients amongst the below listed? (Please grade them from 1 to 6, where 1 = most common and 6 = least common) *

Hypertension
Diabetes
Obesity
CKD
CVD
Others, Please specify

In your clinical practice, in these set of BOO/BPH patients, is Tamsulosin + Dutasteride the preferred combination of Alpha blocker + Dutasteride? *

Yes (If Yes, go to question 7)

No (If No, go to question 5 and 6)

If Q4 NO, what is your preferred combination of Alpha blocker + Dutasteride in these set of patients?

Alfuzosin + Dutasteride

Silodosin + Dutasteride

If Q4 NO, any specific reason which you can highlight for not preferring the combination of Tamsulosin + Dutasteride?

If Q4 YES, how would you rate the combination basis Efficacy, Safety and Tolerability (1= Poor, 2= Average, 3= Good)

Parameter	Poor	Average	Good
Efficacy
Safety
Tolerability

What is the preferred duration of therapy of Alpha blockers + Dutasteride in your clinical practice? *

30 days

30-60 days

60–90 days

90-120 days

>120 days

In your clinical practice, have you observed any significant change in outcome when you switch from one alpha blocker + Dutasteride combination to another alpha blocker + dutasteride in patients with comorbid conditions who no longer respond to the initial treatment? *

Yes (If Yes, go to question number 10)

No (If No, skip question number 10)

If Q9 yes, could you highlight the outcomes observed in your clinical practice?

What is the maximum prostate volume in BPH patients with comorbid conditions where the 1^st line of treatment option would be surgical intervention instead of medical management? *

Any specific comorbidity/comorbidities in BPH patients with enlarged prostate, where you would not prefer the combination of Tamsulosin + Dutasteride as 1^st line of treatment? *

Diabetes

Hypertension

CVD

Obesity

CKD

Osteoporosis

Other

None of the above

Any specific reason which you can state for not considering the combination of Tamsulosin + Dutasteride in patients mentioned in question 12 as 1^st line of treatment?